Please use this identifier to cite or link to this item:
https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6036| Title: | PLASMA FIBROBLASTIC GROWTH FACTOR 23 LEVELS AS PROGNOSTIC BIOMARKER IN CRITICALLY ILL PATIENTS |
| Authors: | ROOPASHREE A. |
| Keywords: | Fibroblast growth factor 23, FGF 23, APACHE II Score. |
| Issue Date: | 2020 |
| Publisher: | BLDE (DU) |
| Abstract: | It is considered that prognostication is one of the most electrolyte important aspect of critical care. Many parameters and scoring scales have been studied and followed in this aspect. FGF-23 is a recently found FGF and functions as an endocrine hormone that regulates phosphorus homeostasis. It has been linked to predict mortality in CKD and AKI and also recently in all critical patients. So we have undertaken this study to evaluate the role of FGF 23 as a prognostic marker in critically ill patients |
| URI: | https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/6036 |
| Appears in Collections: | Department of General Medicine |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ROOPASHREE A-2020.pdf | 2.02 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.